Medical Director, Hematologic Oncology
NateraSalary not specified
Internship
Senior (5 to 8 years)
[Remote] Medical Director, Clinical Development - Dermatology at Abata Therapeutics
Remote
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries
Skills
Key technologies and capabilities for this role
Questions & Answers
Common questions about this position
What is the required education for the Medical Director role?
An MD is required for this position.
What are the company's core values?
The company is founded on C.O.R.E. values: Caring, Original, Resilient, and Egoless.
Is this a remote position or does it require office work?
This information is not specified in the job description.
What is the salary or compensation for this role?
This information is not specified in the job description.
What experience makes an ideal candidate for this role?
Ideal candidates have an MD and experience in clinical development, particularly in overseeing clinical execution and medical monitoring of studies.
Abata Therapeutics
Develops therapies for autoimmune diseases
About Abata Therapeutics
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.
Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees
Risks
Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.
Differentiation
Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.
Upsides
Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.
Related Jobs
RemoteRemoteMedical Director/Clinical Trial Physician - Neurology(FSP)
Thermo Fisher Scientific$200,000 - $250,000/year
- Internship
- Mid-level (3 to 4 years), Senior (5 to 8 years)
RemoteBoard Certified Hematology Physician Advisor, Disability Peer Review
Blank StreetSalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteMedical Science Liaison (Southwest)
ArcellxSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
RemoteChief of Staff - R&D
Addepar$143,000 - $224,000/year
- Full Time
- Expert & Leadership (9+ years)
RemoteClinical Research Physician Pain
Eli Lilly and CompanySalary not specified
- Full Time
- Expert & Leadership (9+ years)
RemoteAssociate Medical Director/Medical Director - Rheumatology/Dermatology
Thermo Fisher ScientificSalary not specified